The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Randomized phase II trial comparing molecularly targeted therapy based on tumor molecular profiling versus conventional therapy in patients with refractory cancer: Results of the SHIVA trial.
 
Christophe Le Tourneau
Honoraria - Boehringer Ingelheim; Caris Life Sciences; Debiopharm Group; Merck Serono; Novartis
 
Jean-Pierre Delord
No Relationships to Disclose
 
Anthony Goncalves
No Relationships to Disclose
 
Celine Gavoille
No Relationships to Disclose
 
Coraline Dubot
No Relationships to Disclose
 
Nicolas Isambert
Honoraria - Merck Serono; Novartis
 
Mario Campone
Honoraria - Novartis; SERVIER
 
Olivier Tredan
Consulting or Advisory Role - Novartis; Roche Pharma AG
 
Cecile Mauborgne
No Relationships to Disclose
 
Sebastien Armanet
No Relationships to Disclose
 
Nicolas Servant
No Relationships to Disclose
 
Ivan Bieche
No Relationships to Disclose
 
Virginie Bernard
No Relationships to Disclose
 
David Gentien
No Relationships to Disclose
 
Pascal Jézéquel
No Relationships to Disclose
 
Valéry Attignon
No Relationships to Disclose
 
Sandrine Boyault
No Relationships to Disclose
 
Anne Vincent-Salomon
No Relationships to Disclose
 
Maud Kamal
No Relationships to Disclose
 
Xavier Paoletti
No Relationships to Disclose